Enliven Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 05/15/2026 | 7.96 M | $312.01 M | 0.00% | 14.05% |
| FMR LLC | 05/15/2026 | 6.83 M | $267.71 M | -3.92% | 12.05% |
| POLAR CAPITAL HOLDINGS PLC | 05/15/2026 | 5.07 M | $198.58 M | 44.18% | 8.94% |
| BLACKROCK, INC. | 05/13/2026 | 3.68 M | $144.44 M | 1.98% | 6.50% |
| COMMODORE CAPITAL LP | 05/15/2026 | 3.28 M | $128.38 M | -30.21% | 5.78% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 3.25 M | $127.40 M | -15.14% | 5.74% |
| BELLEVUE GROUP AG | 05/15/2026 | 2.32 M | $90.98 M | 100.00% | 4.10% |
| 05/15/2026 | 2.17 M | $84.99 M | 100.00% | 3.83% | |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 05/15/2026 | 1.86 M | $72.74 M | -50.00% | 3.27% |
| CITADEL ADVISORS LLC | 05/15/2026 | 1.74 M | $68.36 M | 22.44% | 3.08% |
| VR ADVISER, LLC | 05/15/2026 | 1.73 M | $67.67 M | -46.49% | 3.05% |
| NOVO HOLDINGS A/S | 05/15/2026 | 1.28 M | $50.18 M | -13.51% | 2.26% |
| STATE STREET CORP | 05/15/2026 | 1.09 M | $42.77 M | 3.63% | 1.93% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.07 M | $41.81 M | 1.69% | 1.88% |
| PICTET ASSET MANAGEMENT HOLDING SA | 04/22/2026 | 929.54 K | $36.44 M | -28.67% | 1.64% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 905.19 K | $35.48 M | 233.52% | 1.60% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2026 | 826.50 K | $32.40 M | 3.52% | 1.46% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2026 | 771.89 K | $11.89 M | 1,995.24% | 1.36% |
| SIREN, L.L.C. | 05/14/2026 | 746.23 K | $29.25 M | 100.00% | 1.32% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 681.72 K | $26.71 M | 70.90% | 1.20% |
| FIRST TURN MANAGEMENT, LLC | 05/15/2026 | 623.84 K | $24.45 M | 100.00% | 1.10% |
| CANDRIAM S.C.A. | 04/30/2026 | 594.08 K | $23.29 M | 31.14% | 1.05% |
| 05/14/2026 | 593.04 K | $23.25 M | 100.00% | 1.05% | |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 586.90 K | $23.01 M | 100.00% | 1.04% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 586.50 K | $22.99 M | 100.00% | 1.04% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 540.00 K | $21.17 M | 58.82% | 0.95% |
| MORGAN STANLEY | 05/15/2026 | 518.57 K | $20.33 M | 25.92% | 0.92% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 500.00 K | $19.60 M | 100.00% | 0.88% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 473.12 K | $18.55 M | 99.45% | 0.83% |
| AVIDITY PARTNERS MANAGEMENT LP | 05/28/2026 | 400.00 K | $15.68 M | 185.10% | 0.71% |
| NORTHERN TRUST CORP | 05/14/2026 | 372.32 K | $14.59 M | 5.70% | 0.66% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 370.00 K | $14.50 M | 100.00% | 0.65% |
| CAPRICORN FUND MANAGERS LTD | 04/24/2026 | 369.40 K | $14.48 M | 100.00% | 0.65% |
| STEMPOINT CAPITAL LP | 05/18/2026 | 363.44 K | $14.25 M | 100.00% | 0.64% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 360.58 K | $14.13 M | 1.52% | 0.64% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 345.32 K | $13.54 M | 16.29% | 0.61% |
| 05/15/2026 | 330.96 K | $12.97 M | 100.00% | 0.58% | |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 329.54 K | $12.92 M | 998.47% | 0.58% |
| 05/14/2026 | 329.01 K | $12.90 M | -26.25% | 0.58% | |
| VANGUARD FIDUCIARY TRUST CO | 05/15/2026 | 312.76 K | $12.26 M | 100.00% | 0.55% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 310.03 K | $12.15 M | 100.00% | 0.55% |
| JENNISON ASSOCIATES LLC | 05/06/2026 | 309.18 K | $12.12 M | 100.00% | 0.55% |
| WOODLINE PARTNERS LP | 05/15/2026 | 301.67 K | $11.83 M | 0.22% | 0.53% |
| UBS GROUP AG | 05/05/2026 | 283.54 K | $11.11 M | 389.98% | 0.50% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 230.87 K | $9.05 M | -77.48% | 0.41% |
| EXOME ASSET MANAGEMENT LLC | 05/15/2026 | 220.09 K | $8.63 M | -1.00% | 0.39% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2026 | 218.87 K | $8.58 M | 100.00% | 0.39% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 05/15/2026 | 201.87 K | $7.91 M | 100.00% | 0.36% |
| PATIENT SQUARE CAPITAL LP | 05/15/2026 | 200.00 K | $7.84 M | -35.09% | 0.35% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 193.53 K | $7.59 M | 100.00% | 0.34% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enliven Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 191 institutional investors and hedge funds held shares of Enliven Therapeutics Inc. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 7.96 M
FMR LLC: 6.83 M
Polar Capital Holdings Plc: 5.07 M
BlackRock, Inc.: 3.68 M
COMMODORE CAPITAL LP: 3.28 M
Vestal Point Capital, LP: 3.25 M
110.10% of Enliven Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 65.14 M shares in the last 24 months. This purchase volume represents approximately $1.94 B in transactions.